Use of Vgll3 activity modulator for the modulation of adipogenesis
US8852939B2 · kind B2 · utility
2Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2010 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Jun 9, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/044
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns Vgll3 a new target involved in adipogenesis modulation. Further, the present invention relates to methods to increase Vgll3 activity in adipocytes and preadipocytes. In addition, pharmaceutical composition comprising Vgll3 activity enhancing molecules in order to enhance the Vgll3 activity in a target tissue are also provided. These methods, compositions and molecules can be useful to modulate adipogenesis and thus treat obesity and related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.